Please ensure Javascript is enabled for purposes of website accessibility
Taylor Carmichael

Taylor Carmichael

TMFSaintCroix

Taylor Carmichael is a former attorney and filmmaker. He's the author of a line of murder mysteries, including Whodidit in the Supreme Court? and Whodidit With a Senator? The majority of what he knows about stocks he learned right here at the Motley Fool.

Recent articles

GettyImages-1223150089

Have $3,000? Buying These 2 Stocks Would Be the Smartest Move You Ever Made

Both companies are using nanotechnology to revolutionize healthcare and manufacturing. Plus, they have considerable upside.


Up_938__in_2020,_Is_Co-Diagnostics_Still_a_Buy_in_2021

Up 938% in 2020, Is Co-Diagnostics Still a Buy in 2021?

This diagnostic specialist started off the year as a micro cap, but it roared ahead with its COVID-19 test.


GettyImages-1080967022

Activision Blizzard: Buy or Sell?

It's possible that Wall Street has the wrong idea about what kind of company this video game publisher really is.


Why_the_Market_Is_So_Bullish_About_Trillium_Therapeutics (1)

Why the Market Is So Bullish About Trillium Therapeutics

The cancer biotech soared in 2020, jumping up over 1,000% for the year. What will the stock do in 2021?


After_Its_1,500__Jump,_Is_It_Time_To_Sell_Vaxart_Stock-2

After Its 1,500% Jump, Is It Time to Sell Vaxart Stock?

After the stock's magnificent run in 2020, it might be time to take profits.

Why_the_No._1_Healthcare_Stock_of_2020_Is_Still_a_Buy

Why the No. 1 Healthcare Stock of 2020 Is Still a Buy

Novavax has significant upside if its phase 3 data are positive.


GettyImages-506712124

Is It Too Late to Get In On This Millionaire-Making Stock?

While it's already made some people rich, Axsome Therapeutics is just getting started.


Top_5_Healthcare_Stocks_of_2020_Are_They_Buys_Now

Top 5 Healthcare Stocks of 2020: Are They Buys Now?

These five winners in the healthcare space were all micro-caps at the beginning of the year. How big can they get?


GettyImages-200398520-001

If You Invested $10,000 in Personalis in the Coronavirus Crash, This Is How Much You'd Have Now

Investors weren't very happy when shares tanked in March, but have been smiling ever since.


GettyImages-1251485261

Why I'm Not Buying Vaxart Stock

There are some warning signs around this vaccine-maker that investors should take seriously.

WaltDisneyTheMandalorian

Ubisoft Joins With Disney to Develop New 'Star Wars' Game

Now Ubisoft is hard at work on two Disney properties with massive upside: "Star Wars" and "Avatar."


GettyImages-1281585398

Will IMAX Keep Losing in 2021?

The stock dropped 13% in 2020. Will it recover this year?


GettyImages-649602004

The 10 Best-Performing Stocks of 2020

Biotech, bitcoin, and renewable energy led the way.


GettyImages-1268593533

My 2 Top Small-Cap Stocks to Own In 2021

Silvergate Capital and Ontrak have massive runways for growth in the new year.


GettyImages-823524954

Here's Why You Should Really Own DermTech Stock in 2021

The biotech's skin cancer diagnostic tool is a significant improvement over the standard of care.

GettyImages-843445962

This Stock Could Be a Surprise Growth Pick for 2021

Down 77% in 2020, Amarin's stock should zoom higher once Vascepa obtains European approval.


GettyImages-450806655

Investors in This One Stock Had an Amazing Year

Novavax had the highest returns of any stock on the market in 2020.


GettyImages-1168199832

Here's a Cancer-Killing Stock to Buy for 2021

"Natural killer" (or NK) cancer therapies are hot right now. Here are two stocks that are early leaders in the field -- one is a buy, and the other one is not.


GettyImages-1166057429

Why Is Everybody Talking About Novavax Stock?

Its coronavirus vaccine could make it an even bigger winner.


GettyImages-1135068422

Why Peter Lynch Would Love Freshpet Stock

This dog food stock has been an incredible 16-bagger over the last five years.